enzyme antagonist

Conclusion: Ang ⅱ may play an important role in the pathogenesis of DED, and the Ang ⅱ antagonist or inhibitor of the angiotensin-converting enzyme ( ACEI) may become a therapeutic method for DED in the future.

结论AngⅡ在DED大鼠血浆及海绵体组织中显著升高，在DED的发病中可能具有重要作用，血管紧张素转化酶抑制剂（ACEI）或AngⅡ受体拮抗剂有望成为治疗DED的重要方法之一。

Merck Co. had a promising CGRP-receptor antagonist under development but discovered in late-stage clinical-trial testing that some patients experienced liver enzyme changes.

默克公司（Merck Co.）曾经研制了一种让人看好的CGRP感受器官拮抗药，但是在后期的临床测试中发现，有些患者出现了肝脏改变的情况。

Merck& Co. had a promising CGRP-receptor antagonist under development but discovered in late-stage clinical-trial testing that some patients experienced liver enzyme changes.

默克公司（Merck&Co.）曾经研制了一种让人看好的CGRP感受器官拮抗药，但是在后期的临床测试中发现，有些患者出现了肝脏改变的情况。